Rimegepant for Migraine: Treatment & Prevention Guide
Complete guide to rimegepant (Vydura): how it works, dosage, and effectiveness for acute migraine treatment and prevention.
About Rimegepant for Migraine Headache
Rimegepant, commonly known by its brand name Vydura, is a prescription medication that offers a dual approach to migraine management. It can be used to treat an active migraine headache when symptoms first appear, or taken regularly to prevent migraine attacks from occurring in the first place. This innovative medication belongs to a class of drugs called CGRP-receptor blockers (also known as gepants), representing a significant advancement in migraine therapy.
What Type of Medicine is Rimegepant?
| Characteristic | Details |
|---|---|
| Type of Medicine | CGRP-receptor blocker (Gepant) |
| Used For | Treating and preventing migraine headaches in adults aged 18 years or older |
| Brand Name | Vydura (also available as Nurtec ODT in the USA) |
| Available Form | Melt-in-the-mouth orodispersible tablets (75mg) |
| Prescription Required | Yes, available only with doctor’s prescription |
How Does Rimegepant Work?
Although the exact mechanisms of migraine are still being researched, scientists have identified a key player in migraine attacks: a substance called calcitonin gene-related peptide (CGRP). People who experience migraines often have elevated levels of CGRP in their brain and body. Rimegepant works by blocking the action of CGRP by attaching to its receptor sites in the brain, effectively interrupting the cascade of events that lead to migraine pain and symptoms.
By inhibiting CGRP receptors, rimegepant reduces inflammation and nerve pain associated with migraines. This mechanism allows the medication to accomplish two important goals: it can stop an active migraine attack that is already underway, and it can reduce the number and frequency of migraine attacks over time when taken as a preventive treatment.
Who Should Use Rimegepant?
Rimegepant is prescribed for adults aged 18 years and older and is particularly suitable for specific migraine situations. According to clinical guidelines, rimegepant is recommended for:
- Acute migraine treatment: To relieve pain and associated symptoms (such as nausea, light sensitivity, and sound sensitivity) during a migraine attack, whether the migraine occurs with or without aura.
- Preventive treatment: To reduce the number of episodic migraine attacks in adults who experience at least four migraine attacks per month.
- Rescue medication for chronic migraine: As a ‘rescue medication’ for people with chronic migraine to reduce pain intensity when attacks occur.
Rimegepant may be particularly beneficial for individuals who have found that traditional pain relievers such as paracetamol and ibuprofen do not work adequately, or for those who are unable to take triptans due to contraindications or intolerance.
Dosage and Administration
Rimegepant comes as melt-in-the-mouth orodispersible tablets that disintegrate quickly on the tongue, requiring no water for administration. The dosage varies depending on how the medication is being used:
For Acute Migraine Treatment
When using rimegepant to treat an active migraine attack, the standard dose is 75mg taken as needed at the first sign of migraine symptoms. The medication should be taken at the start of a migraine to prevent it from continuing and worsening. Importantly, you should never exceed 75mg in a 24-hour period, meaning you can take a maximum of one tablet per day.
For Migraine Prevention
When taking rimegepant to prevent migraines and reduce the frequency of attacks, the typical dose is 75mg every other day (on alternate days). This regular dosing schedule helps maintain consistent levels of CGRP receptor blockade to prevent attacks from developing. As with acute treatment, you should never exceed a total daily dose of 75mg.
How Effective is Rimegepant?
Clinical research has demonstrated the effectiveness of rimegepant in both acute treatment and prevention of migraines. When rimegepant is taken to treat an active migraine attack, most people experience freedom from their worst migraine symptoms within 2 hours. This relatively rapid onset of action makes it a practical choice for acute migraine management.
In clinical trials, rimegepant has shown efficacy in treating acute migraine with results superior to placebo for providing pain relief at the 2-hour mark. For preventive use, studies have evaluated rimegepant’s ability to reduce monthly migraine days and achieve at least a 50% reduction in the number of moderate to severe migraine days.
Rimegepant represents an important innovation as the first treatment that works effectively for both acute therapy and as a preventive option, offering patients flexibility in how they use the medication. It is also notable that rimegepant does not appear to increase the chance of developing chronic migraines and carries a generally tolerable side effects profile compared to existing options.
Advantages of Rimegepant Over Other Treatments
Rimegepant offers several distinctive advantages that make it an attractive option for many migraine sufferers:
- Dual indication: Rimegepant is the first treatment approved for both acute and preventive treatment of episodic migraine, providing flexibility for patients.
- Oral administration: As the first oral alternative to injectable preventative options, rimegepant can be prescribed in primary care settings without requiring specialist training or setup costs.
- No medication overuse headache: Unlike some traditional migraine medications, rimegepant offers the significant benefit of not causing medication overuse headache (MOH), which is a serious concern for many migraine patients who use acute treatments frequently.
- Good tolerability: The medication is generally well-tolerated with a favorable side effects profile.
- Reduced healthcare visits: By effectively managing migraines, rimegepant use can reduce emergency room and acute care visits for migraine management.
When is Rimegepant Prescribed?
Healthcare providers typically prescribe rimegepant in specific clinical situations. For acute treatment, rimegepant can be prescribed by hospital specialists or general practice surgeons (GPs) when a patient experiences an active migraine attack. For preventive treatment, it is usually prescribed when traditional prevention methods have proven inadequate or unsuitable.
Many people find current acute and preventive migraine treatments available through standard healthcare options unsuitable due to side effects, contraindications, or lack of efficacy in managing their symptoms. Rimegepant serves as an alternative for these patients, particularly those who:
- Experience intolerable side effects from other migraine medications
- Have contraindications to conventional treatments such as triptans
- Have not achieved adequate symptom relief with standard pain relievers
- Are at high risk of medication overuse headache
- Require a medication that works for both acute treatment and prevention
Special Considerations
It is important to note that rimegepant is specifically designed for treating and preventing migraine headaches. It is not an ordinary pain reliever and will not relieve pain from other conditions. The medication works uniquely on the migraine pathway and should only be used as directed by a healthcare provider.
For individuals with chronic migraine (defined as having more than eight migraines and fifteen headache days each month), rimegepant can serve as a rescue medication to manage pain intensity during attacks, offering an additional tool in their migraine management strategy.
Frequently Asked Questions
Q: What is the difference between using rimegepant for acute treatment versus prevention?
A: For acute treatment, rimegepant 75mg is taken at the first sign of a migraine to stop the attack. For prevention, 75mg is taken every other day regularly to reduce the number of migraine attacks you experience overall. Both use the same dose but differ in frequency and timing of administration.
Q: How quickly does rimegepant work when treating an active migraine?
A: Most people experience freedom from their worst migraine symptoms within 2 hours of taking rimegepant for acute treatment. This relatively rapid action makes it practical for managing active migraines.
Q: Can rimegepant be taken with other medications?
A: You should discuss all medications you take with your healthcare provider before using rimegepant. Your doctor can determine if rimegepant is safe to use alongside your current medications and can adjust your treatment plan accordingly.
Q: Is rimegepant suitable for migraines with or without aura?
A: Yes, rimegepant is approved for treating migraines with or without aura, making it suitable for a broad spectrum of migraine sufferers.
Q: Does rimegepant cause medication overuse headache?
A: No, one of the significant advantages of rimegepant is that it does not cause medication overuse headache (MOH), which is a concern with some traditional migraine treatments used frequently.
Q: What age group can use rimegepant?
A: Rimegepant is approved for adults aged 18 years and older. It is not recommended for children under 18 at this time.
Q: If I miss a dose of preventive rimegepant, what should I do?
A: If you miss a scheduled dose of rimegepant when taking it for prevention, take it as soon as you remember unless it is close to the time for your next dose. Never double up on doses. Consult your healthcare provider for specific guidance on your situation.
References
- Rimegepant for migraine headache — Patient.info. Accessed 2026-01-13. https://patient.info/medicine/rimegepant-for-migraine-headache-vydura
- Rimegepant: Patient Information — Torbay and South Devon NHS. 2025-12-20. https://www.torbayandssouthdevon.nhs.uk/
- Rimegepant: MedlinePlus Drug Information — U.S. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a620031.html
- Rimegepant For Treating a Migraine Attack: Patient Information — South Yorkshire ICB NHS. https://mot.southyorkshire.icb.nhs.uk/
- Rimegepant for the treatment of migraine — Berger AA. Health Policy Review, 2022. https://healthpr.org/journal/HPR/10/5/10.52965/001c.38534
- Rimegepant for treating or preventing migraine — National Institute for Health and Care Excellence (NICE). TA919. https://www.nice.org.uk/guidance/ta919
- Rimegepant treatment for migraine — University Hospitals Sussex NHS. 2024-05. https://www.uhsussex.nhs.uk/
- Rimegepant (oral route) – Side effects & dosage — Mayo Clinic. https://www.mayoclinic.org/drugs-supplements/rimegepant-oral-route/description/drg-20484237
Similar Articles
Read full bio of Sneha Tete
